Clinical Trials – SRK BHARAT

Moderna and Merck Advance Personalized mRNA Cancer Vaccine Trials as Shares Rise

Biotechnology firm Moderna and pharmaceutical giant Merck announced significant clinical progress in the development of their experimental messenger RNA cancer vaccine. The innovative treatment aims to target individual patient tumors…

srkanalytics.srk@gmail.com August 20, 2026

Business

Moderna Stock Surges as Melanoma Vaccine Trial Shows Landmark Moment

Biotechnology firm Moderna saw a significant surge in its stock value following the release of highly anticipated clinical trial results for a personalized messenger RNA melanoma vaccine. Developed in partnership…

srkanalytics.srk@gmail.com August 20, 2026

Health

Moderna and Merck Announce Breakthrough Results in Experimental Melanoma Vaccine Trial

Biotechnology firm Moderna and pharmaceutical giant Merck announced groundbreaking clinical trial results this week, revealing that their experimental messenger RNA (mRNA) cancer vaccine significantly reduces the risk of melanoma recurrence…

srkanalytics.srk@gmail.com August 20, 2026

Health

Prediction Markets Expand Into Clinical Trials and Drug Approvals, Raising Ethical Concerns

Financial speculators can now wager real money on pharmaceutical outcomes as prediction platforms like Kalshi and Polymarket introduce contracts tied to federal drug approvals and clinical trial results. This emerging…

srkanalytics.srk@gmail.com August 2, 2026

Health

Nature Medicine Retracts Controversial Study on Circadian Cancer Therapy

The prestigious journal Nature Medicine officially retracted a high-profile clinical trial study this week, citing significant concerns regarding the integrity of its data. The research, which purported that cancer patients…

srkanalytics.srk@gmail.com June 29, 2026